FDA Approved: ALFUZOSIN HYDROCHLORIDE EXTENDED RELEASE — Original Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved Cipla USA Inc.'s alfuzosin hydrochloride extended-release as an Original Application, providing a generic option for treating symptoms of benig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• ALFUZOSIN HYDROCHLORIDE EXTENDED RELEASE (alfuzosin hydrochloride extended-release)

Snippet

ORIG AP for ALFUZOSIN HYDROCHLORIDE EXTENDED RELEASE (ALFUZOSIN HYDROCHLORIDE)